Original Article
Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis?
¿Cuáles son los factores de riesgo para el cambio de bDMARD en el primer año de terapia debido a la falta de eficacia en pacientes con artritis reumatoide?
Ana Martinsa,
, Sofia Pimentaa,b, Daniela Oliveiraa,c, Rafaela Nicolaud, Alexandra Bernardoa, Teresa Martins Rochaa,b, Lúcia Costaa, Miguel Bernardesa,b
Corresponding author
a Rheumatology Department, Centro Hospitalar Universitário São João, Porto, Portugal
b Medicine Department, Faculty of Medicine, University of Porto, Porto, Portugal
c Center for Health Technology and Services Research (CINTESIS), Faculty of Medicine, University of Porto, Porto, Portugal
d Rheumatology Department, Centro Hospitalar Tondela-Viseu, Viseu, Portugal
Read
1222
Timeswas read the article
581
Total PDF
641
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 148 | 35 | 183 |
| 2025 10 | 20 | 60 | 80 |
| 2025 9 | 0 | 55 | 55 |
| 2025 8 | 0 | 83 | 83 |
| 2025 7 | 0 | 67 | 67 |
| 2025 6 | 5 | 39 | 44 |
| 2025 5 | 136 | 78 | 214 |
| 2025 4 | 98 | 56 | 154 |
| 2025 3 | 107 | 48 | 155 |
| 2025 2 | 102 | 47 | 149 |
| 2025 1 | 14 | 7 | 21 |
| 2024 11 | 2 | 4 | 6 |
| 2024 10 | 2 | 0 | 2 |
| 2024 9 | 2 | 0 | 2 |
| 2024 8 | 5 | 2 | 7 |
Show all
